Financhill
Buy
63

SXI Quote, Financials, Valuation and Earnings

Last price:
$150.96
Seasonality move :
3.37%
Day range:
$150.06 - $153.73
52-week range:
$128.85 - $212.66
Dividend yield:
0.84%
P/E ratio:
29.83x
P/S ratio:
2.42x
P/B ratio:
2.65x
Volume:
64.1K
Avg. volume:
81.8K
1-year change:
-8.92%
Market cap:
$1.8B
Revenue:
$720.6M
EPS (TTM):
$5.06

Analysts' Opinion

  • Consensus Rating
    Standex International has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $197.00, Standex International has an estimated upside of 30.52% from its current price of $150.94.
  • Price Target Downside
    According to analysts, the lowest downside price target is $175.00 representing 100% downside risk from its current price of $150.94.

Fair Value

  • According to the consensus of 2 analysts, Standex International has 30.52% upside to fair value with a price target of $197.00 per share.

SXI vs. S&P 500

  • Over the past 5 trading days, Standex International has overperformed the S&P 500 by 0.57% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Standex International does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Standex International has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Standex International reported revenues of $207.8M.

Earnings Growth

  • Standex International has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Standex International reported earnings per share of $1.81.
Enterprise value:
2.3B
EV / Invested capital:
1.79x
Price / LTM sales:
2.42x
EV / EBIT:
27.44x
EV / Revenue:
3.10x
PEG ratio (5yr expected):
--
EV / Free cash flow:
60.37x
Price / Operating cash flow:
47.12x
Enterprise value / EBITDA:
19.85x
Gross Profit (TTM):
$293.4M
Return On Assets:
4.98%
Net Income Margin (TTM):
8.09%
Return On Equity:
9.18%
Return On Invested Capital:
6.23%
Operating Margin:
14.62%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $737.5M $728.8M $748.3M $177.3M $207.8M
Gross Profit $278M $286.2M $293.4M $68.3M $82.4M
Operating Income $105.5M $112.9M $111.6M $26.4M $30.4M
EBITDA $188.2M $129.6M $116.8M $28.4M $35.7M
Diluted EPS $11.09 $6.18 $5.06 $1.33 $1.81
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $350.8M $410.6M $460.8M $419.2M $486.9M
Total Assets $946.3M $973.6M $1B $993.5M $1.6B
Current Liabilities $131.9M $141.7M $130.6M $122.3M $143.1M
Total Liabilities $463.7M $445.9M $409.5M $374.5M $840.1M
Total Equity $482.7M $527.6M $605.6M $619M $714.5M
Total Debt $200.1M $199.7M $173.3M $148.8M $579.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $79.8M $104.6M $64.7M $24.4M $9.5M
Cash From Investing $35.3M -$61.4M -$501M -$16.4M -$63.9M
Cash From Financing -$69M -$75.9M $408.1M -$8.5M $41.4M
Free Cash Flow $52.4M $83.2M $38.4M $19.2M $3.5M
SXI
Sector
Market Cap
$1.8B
$602.8M
Price % of 52-Week High
70.98%
77.23%
Dividend Yield
0.84%
0%
Shareholder Yield
-3.19%
2.32%
1-Year Price Total Return
-8.92%
-3.86%
Beta (5-Year)
1.078
0.777
Dividend yield:
0.84%
Annualized payout:
$1.18
Payout ratio:
24.33%
Growth streak:
14 years

Technicals

8-day SMA
Sell
Level $151.15
200-day SMA
Sell
Level $176.96
Bollinger Bands (100)
Sell
Level 148.46 - 187.96
Chaikin Money Flow
Buy
Level 7.9M
20-day SMA
Sell
Level $154.08
Relative Strength Index (RSI14)
Sell
Level 48.79
ADX Line
Buy
Level 20.76
Williams %R
Neutral
Level -65.8747
50-day SMA
Buy
Level $150.44
MACD (12, 26)
Buy
Level 0.16
25-day Aroon Oscillator
Buy
Level 44
On Balance Volume
Neutral
Level 9.5M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (5.8836)
Buy
CA Score (Annual)
Level (0.7401)
Buy
Beneish M-Score (Annual)
Level (-2.5187)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.7451)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

Stock Forecast FAQ

In the current month, SXI has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SXI average analyst price target in the past 3 months is $197.00.

  • Where Will Standex International Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Standex International share price will rise to $197.00 per share over the next 12 months.

  • What Do Analysts Say About Standex International?

    Analysts are divided on their view about Standex International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Standex International is a Sell and believe this share price will drop from its current level to $175.00.

  • What Is Standex International's Price Target?

    The price target for Standex International over the next 1-year time period is forecast to be $197.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is SXI A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Standex International is a Buy. 2 of 2 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of SXI?

    You can purchase shares of Standex International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Standex International shares.

  • What Is The Standex International Share Price Today?

    Standex International was last trading at $150.96 per share. This represents the most recent stock quote for Standex International. Yesterday, Standex International closed at $150.94 per share.

  • How To Buy Standex International Stock Online?

    In order to purchase Standex International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock